Literature DB >> 20931526

[Association of the ABCG1 gene polymorphism with the susceptibility and severity of coronary atherosclerotic disease].

Long Ma1, Guang-hui Cheng, Hui Wang, Li Li, Yao-qin Gong, Qi-ji Liu.   

Abstract

OBJECTIVE: To investigate the association of the ATP-binding cassette sub-family G member 1 (ABCG1) gene polymorphisms with coronary atherosclerotic disease (CAD) in Chinese Han population.
METHODS: A population based case-control association study was carried out in 541 patients with CAD and 649 healthy controls from Chinese Han population. Two single nucleotide polymorphisms (SNPs) of the ABCG1 gene were genotyped using polymerase chain reaction-restriction fragment length polymorphism. Logistic regression was used to compare the genotypic and allelic frequency difference.
RESULTS: The frequency of allele C of rs225374 was significantly higher in the CAD patients than that in the healthy controls (OR=1.186, 95%CI: 1.009-1.394, P=0.039), while the difference was also significant in the male subgroup (OR=1.236, 95%CI: 1.014-1.506, P=0.036). A statistically higher frequency of rs1044317 allele A was found in the CAD patients in comparison to the healthy controls (OR=1.187, 95%CI: 1.009-1.397, P=0.039). In case-only association study, rs225374 showed significant association in the high Gensini score group compared with the low Gensini score group (OR=1.303, 95%CI: 1.024-1.657, P=0.031).
CONCLUSION: The two SNPs of the ABCG1 gene might be associated with the susceptibility and severity of CAD in Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20931526     DOI: 10.3760/cma.j.issn.1003-9406.2010.05.007

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  1 in total

1.  A study of the association of rs12040273 with susceptibility and severity of coronary artery disease in a Chinese Han population.

Authors:  Bo Yang; Shan Yan; Jianjun Yan; Yafei Li; Mohammad Reeaze Khurwolah; Liansheng Wang; Zhong Chen
Journal:  BMC Cardiovasc Disord       Date:  2018-01-19       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.